Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PegBio CoHKSE:02565 +23.59%11 Quick Ratio is 3.94 as of Dec. 2025, which is 49% above its 10-year median of 2.65. GuruFocus rates HKSE:02565 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 1,410 Biotechnology companies, PegBio Co ranks better than 52.7% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. PegBio Co's quick ratio for the quarter that ended in Dec. 2025 was 3.94.
PegBio Co has a quick ratio of 3.94. It generally indicates good short-term financial strength.
The historical rank and industry rank for PegBio Co's Quick Ratio or its related term are showing as below:
HKSE:02565'
s Quick Ratio Range Over the Past 10 Years
Min: 1.21 Med: 2.65 Max: 3.94
Current: 3.94
During the past 4 years, PegBio Co's highest Quick Ratio was 3.94. The lowest was 1.21. And the median was 2.65.
HKSE:02565's Quick Ratio is ranked better than 52.7% of 1410
companies
in the Biotechnology industry
Industry Median: 3.58
vs HKSE:02565: 3.94
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
PegBio Co Quick Ratio Related Terms
PegBio Co Quick Ratio Historical Data
* Premium members only.
The historical data trend for PegBio Co's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02565 vs VRTX, REGN, RVMD: Quick Ratio Comparison
For the Biotechnology subindustry, PegBio Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PegBio Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PegBio Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where PegBio Co's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
PegBio Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PegBio Co (HKSE:02565) has a Quick Ratio of 3.94 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PegBio Co and its competitors. This is 49% above median its historical median of 2.65. Over the past decade, PegBio Co's Quick Ratio has ranged from 1.21 to 3.94. According to the industry distribution chart, PegBio Co ranks #667 out of 1410 companies in the Biotechnology industry, placing it in the top 47.3%.
Is PegBio Co's Quick Ratio too high?
PegBio Co's current Quick Ratio of 3.94 is 49% above median its 10-year median of 2.65. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 3.94. The Biotechnology industry median Quick Ratio is 3.58. PegBio Co's value of 3.94 is 10.1% above this industry median. Based on the distribution chart, PegBio Co ranks #667 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, PegBio Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does PegBio Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PegBio Co ranks #667 out of 1410 companies for Quick Ratio. This puts PegBio Co in the upper half of its industry. The industry median Quick Ratio is 3.58. PegBio Co's value of 3.94 is 10.1% above this benchmark. Historically, PegBio Co's own Quick Ratio has ranged from 1.21 to 3.94 over the past decade. While the company's 10-year median is 2.65 vs. the industry median of 3.58, PegBio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.58, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PegBio Co's current Quick Ratio of 3.94 is 10.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PegBio Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PegBio Co's current Quick Ratio is 3.94, which is 49% above median its own 10-year median of 2.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PegBio Co stock overvalued right now?
PegBio Co (HKSE:02565) has a current Quick Ratio of 3.94. The current Quick Ratio is 3.94, which is 49% above median its 10-year median of 2.65 and 10.1% above the Biotechnology industry median of 3.58. PegBio Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For PegBio Co (HKSE:02565), the current Quick Ratio is 3.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PegBio Co Ltd is engaged in the discovery and development of therapies. The company's main product PB-119, is a self-developed, obtained marketing approval from the National Medical Products Administration (NMPA) and entered commercialization preparation stage, long-acting glucagonlike peptide 1 (GLP-1, a peptide hormone that decreases blood sugar levels) receptor agonist. The Company's product candidates include PB-718, PB-1902, PB-722, PB-2301 and PB-2309.
11GF Score
Get the complete analysis for HKSE:02565
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02565 has been successfully added to your 
